Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Etripamil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Milestone Pharmaceuticals to Host Investor KOL Event
    Milestone Pharmaceuticals to Host Investor KOL Event

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2952137/0/en/Milestone-Pharmaceuticals-to-Host-Investor-KOL-Event.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share
    Milestone Partner Ji Xing Pharma, Positive Result of Ph 3 Study in PSVT in China
    Milestone Partner Ji Xing Pharma, Positive Result of Ph 3 Study in PSVT in China

    07 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942068/0/en/Milestone-Partner-Ji-Xing-Pharmaceuticals-Ltd-Announces-Positive-Topline-Results-from-the-Phase-3-Study-of-Etripamil-in-PSVT-in-China.html

    GLOBENEWSWIRE
    07 Sep 2024
    Share Share
    Milestone Partner Ji Xing Reports Positive Ph 3 Results For Etripamil In PSVT
    Milestone Partner Ji Xing Reports Positive Ph 3 Results For Etripamil In PSVT

    07 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942068/0/en/Milestone-Partner-Ji-Xing-Pharmaceuticals-Ltd-Announces-Positive-Topline-Results-from-the-Phase-3-Study-of-Etripamil-in-PSVT-in-China.html

    GLOBENEWSWIRE
    07 Sep 2024
    Share Share
    Milestone Pharmaceuticals Adds Joseph Papa To Board
    Milestone Pharmaceuticals Adds Joseph Papa To Board

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940428/0/en/Milestone-Pharmaceuticals-Appoints-Industry-Veteran-Joseph-Papa-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
    Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024

    26 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/26/2935443/0/en/Milestone-Pharmaceuticals-to-Present-Data-on-Etripamil-at-the-ESC-Congress-2024.html

    GLOBENEWSWIRE
    26 Aug 2024
    Share Share
    Milestone Pharma Reports Q1 2024 Results, Regulatory And Corporate Update
    Milestone Pharma Reports Q1 2024 Results, Regulatory And Corporate Update

    13 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/13/2880300/0/en/Milestone-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Regulatory-and-Corporate-Update.html

    GLOBENEWSWIRE
    13 May 2024
    Share Share